Paul Bien
Impact in
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus
- Antifungal resistance and susceptibility
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antifungal resistance and susceptibility 10
- Antimicrobial Resistance in Staphylococcus 7
-
- Fungal Infections and Studies 6
- Nail Diseases and Treatments 5
- Co-authors
- Philippe Prokocimer (4 shared papers)Michael A. Pfaller (6 shared papers)Mariana Castanheira (6 shared papers)Michael D. Huband (6 shared papers)Ken Bartizal (2 shared papers)Robert K. Flamm (3 shared papers)Shawn D. Flanagan (1 shared paper)Sonia L. Minassian (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (7 papers)Open Forum Infectious Diseases (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)Diagnostic Microbiology and Infectious Disease (1 paper)Surgical Infections (1 paper)
- Partner nations
- United StatesUnited KingdomSlovakia
In The Last Decade
Paul Bien
18 papers receiving 608 citations
Peers
Comparison fields: 5 of 58
- Infectious Diseases 512
- Molecular Medicine 113
- Clinical Biochemistry 138
- Applied Microbiology and Biotechnology 26
- Pharmacology 152
Countries citing papers authored by Paul Bien
This map shows the geographic impact of Paul Bien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Bien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Bien more than expected).
Fields of papers citing papers by Paul Bien
This network shows the impact of papers produced by Paul Bien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Bien. The network helps show where Paul Bien may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Bien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 97 | |
| 2 | 2013 | 83 | |
| 3 | 2012 | 77 | |
| 4 | 2019 | 67 | |
| 5 | 2014 | 61 | |
| 6 | 2023 | 54 | |
| 7 | 2021 | 43 | |
| 8 | 2023 | 37 | |
| 9 | 1985 | 28 | |
| 10 | 2014 | 25 | |
| 11 | 2022 | 19 | |
| 12 | 1988 | 10 | |
| 13 | 2024 | 10 | |
| 14 | 2014 | 8 | |
| 15 | Human Pharmacokinetics of TR-700 after Ascending Single Oral Doses of the Prodrug TR-701, a Novel Oxazolidinone Antibiotic | 2008 | 6 |
| 16 | 1986 | 5 | |
| 17 | 2022 | 2 | |
| 18 | 2020 | 2 |
About Paul Bien
Paul Bien is a scholar working on Infectious Diseases, Epidemiology, Pharmacology, Molecular Biology and Molecular Medicine, having authored 18 papers that have together received 634 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (10 papers), Antimicrobial Resistance in Staphylococcus (7 papers), Fungal Infections and Studies (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Nail Diseases and Treatments (5 papers), Antibiotic Resistance in Bacteria (4 papers), Bacterial biofilms and quorum sensing (3 papers) and Bacterial Identification and Susceptibility Testing (2 papers). The work is most often cited by research in Infectious Diseases (512 citations), Molecular Medicine (113 citations), Clinical Biochemistry (138 citations), Applied Microbiology and Biotechnology (26 citations) and Pharmacology (152 citations). Paul Bien has collaborated with scholars based in United States, United Kingdom and Slovakia. Frequent co-authors include Philippe Prokocimer, Michael A. Pfaller, Mariana Castanheira, Michael D. Huband, Ken Bartizal, Robert K. Flamm, Shawn D. Flanagan, Sonia L. Minassian, Chris M. Pillar and Jürgen B. Bulitta. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Open Forum Infectious Diseases, Journal of Antimicrobial Chemotherapy, Diagnostic Microbiology and Infectious Disease and Surgical Infections.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.